BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33394377)

  • 1. SS18 Break-Apart Fluorescence In Situ Hybridization is a Practical and Effective Method for Diagnosing Microsecretory Adenocarcinoma of Salivary Glands.
    Bishop JA; Koduru P; Veremis BM; Oliai BR; Weinreb I; Rooper LM; Dickson BC; Demicco EG
    Head Neck Pathol; 2021 Sep; 15(3):723-726. PubMed ID: 33394377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsecretory Adenocarcinoma: A Novel Salivary Gland Tumor Characterized by a Recurrent MEF2C-SS18 Fusion.
    Bishop JA; Weinreb I; Swanson D; Westra WH; Qureshi HS; Sciubba J; MacMillan C; Rooper LM; Dickson BC
    Am J Surg Pathol; 2019 Aug; 43(8):1023-1032. PubMed ID: 31094920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsecretory adenocarcinoma of the skin harboring recurrent SS18 fusions: A cutaneous analog to a newly described salivary gland tumor.
    Bishop JA; Williams EA; McLean AC; Gagan J; Rooper LM; Jordan RCK; LeBoit PE
    J Cutan Pathol; 2023 Feb; 50(2):134-139. PubMed ID: 35690998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsecretory Adenocarcinoma of Salivary Glands: An Expanded Series of 24 Cases.
    Bishop JA; Sajed DP; Weinreb I; Dickson BC; Bilodeau EA; Agaimy A; Franchi A; Khurram SA; Da Forno P; Robledo J; Kalmar JR; Aguirre S; Krane JF; Tapia JL; Kiss K; Cordell K; Rosebush M; Barrett AW; Oda D; Assaad A; Nagao T; Kawakami F; Nakaguro M; Zahir I; Wakeman K; Ihrler S; Chenevert J; Lin YL; Westra WH; Gagan J; Rooper LM
    Head Neck Pathol; 2021 Dec; 15(4):1192-1201. PubMed ID: 33982215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsecretory adenocarcinoma: Cutaneous counterpart of a newly described salivary gland tumor with recurrent MEF2C::SS18 fusion.
    Panse G
    J Cutan Pathol; 2023 Feb; 50(2):188-190. PubMed ID: 36308392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microcribriform Adenocarcinoma of Salivary Glands: A Unique Tumor Entity Characterized by an SS18::ZBTB7A Fusion.
    Weinreb I; Hahn E; Dickson BC; Rooper LM; Rupp NJ; Freiberger SN; Lubin D; Gagan J; Bishop JA
    Am J Surg Pathol; 2023 Feb; 47(2):194-201. PubMed ID: 36221318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsecretory adenocarcinoma of the external ear canal.
    Dibbern ME; Gru AA; Stelow EB
    J Cutan Pathol; 2023 Feb; 50(2):106-109. PubMed ID: 35710690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsecretory Adenocarcinoma of the Ear Canal: Novel Cutaneous Analog of a Salivary Gland Neoplasm.
    Chan MP; Flack AB; Grisel JJ; Harms PW; McHugh JB
    Am J Dermatopathol; 2022 Nov; 44(11):855-858. PubMed ID: 35925564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
    Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
    Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unknown partner for USP6 and unusual SS18 rearrangement detected by fluorescence in situ hybridization in a solid aneurysmal bone cyst.
    Geiersbach K; Rector LS; Sederberg M; Hooker A; Randall RL; Schiffman JD; South ST
    Cancer Genet; 2011 Apr; 204(4):195-202. PubMed ID: 21536237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsecretory adenocarcinoma of the hard palate: A case report of a recently described entity.
    Kawakami F; Nagao T; Honda Y; Sakata J; Yoshida R; Nakayama H; Inoue S; Kitajima M; Ikeda O; Nakaguro M; Mikami Y
    Pathol Int; 2020 Oct; 70(10):781-785. PubMed ID: 32687666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma.
    Clauditz TS; Gontarewicz A; Wang CJ; Münscher A; Laban S; Tsourlakis MC; Knecht R; Sauter G; Wilczak W
    Diagn Mol Pathol; 2012 Sep; 21(3):134-7. PubMed ID: 22847156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKX3.1 Expression and Molecular Characterization of Secretory Myoepithelial Carcinoma (SMCA): Advancing the Case for a Salivary Mucous Acinar Phenotype.
    Patel S; Wald AI; Bastaki JM; Chiosea SI; Singhi AD; Seethala RR
    Head Neck Pathol; 2023 Jun; 17(2):467-478. PubMed ID: 36746884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.
    Motoi T; Kumagai A; Tsuji K; Imamura T; Fukusato T
    Hum Pathol; 2010 Oct; 41(10):1397-404. PubMed ID: 20594581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsecretory Adenocarcinoma of Salivary Glands.
    Bishop JA; Sajed DP
    Adv Anat Pathol; 2023 Mar; 30(2):130-135. PubMed ID: 36729381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlating SS18-SSX immunohistochemistry (IHC) with SS18 fluorescent in situ hybridization (FISH) in synovial sarcomas: a study of 36 cases.
    Tay TKY; Sukma NB; Lim TH; Kuick CH; Goh JY; Chang KTE
    Virchows Arch; 2021 Oct; 479(4):785-793. PubMed ID: 34091760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component.
    Skálová A; Weinreb I; Hyrcza M; Simpson RH; Laco J; Agaimy A; Vazmitel M; Majewska H; Vanecek T; Talarčik P; Manajlovic S; Losito SN; Šteiner P; Klimkova A; Michal M
    Am J Surg Pathol; 2015 Mar; 39(3):338-48. PubMed ID: 25581728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel SSX1 fusions in synovial sarcoma.
    Yoshida A; Arai Y; Satomi K; Kubo T; Ryo E; Matsushita Y; Hama N; Sudo K; Komiyama M; Yatabe Y; Shibata T; Ichikawa H; Ichimura K; Kawai A; Mori T
    Mod Pathol; 2022 Feb; 35(2):228-239. PubMed ID: 34504309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets.
    Freiberger SN; Brada M; Fritz C; Höller S; Vogetseder A; Horcic M; Bihl M; Michal M; Lanzer M; Wartenberg M; Borner U; Bode PK; Broglie MA; Rordorf T; Morand GB; Rupp NJ
    Neoplasia; 2021 May; 23(5):473-487. PubMed ID: 33878706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
    Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK
    Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.